Navigation Links
Marrone Bio Innovations Establishes International Science Advisory Panel
Date:11/20/2013

DAVIS, Calif., Nov. 20, 2013 /PRNewswire/ -- Marrone Bio Innovations, Inc. (MBI) [NASDAQ: MBII], a leading global provider of bio-based pest management and plant health products, announced the establishment of an International Science Advisory Panel (ISAP). Emeritus Professor Alison Stewart, MBI Chief Science Officer, explains its mission, "MBI believes it is essential to have rigorous external critique of our strategic and operational framework. The ISAP will provide a powerful vehicle for driving innovation and it will enable us to keep a pulse on the global biopesticide research landscape and stay at the leading edge of this burgeoning industry."

(Logo: http://photos.prnewswire.com/prnh/20130814/SF63633LOGO)

The panel is comprised of recognized leading authorities in a variety of scientific disciplines. Their broad expertise will be key in fulfilling the panel's role to provide strategic advice on R&D approaches and directions, offer technical input on new technologies and give critical commentary on global opportunities and threats in the biopesticide area.

Members of the International Science Advisory Panel and their areas of expertise are:

  • Professor Lodovica Gullino—Director Agroinnova, University of Torino, Italy; plant disease biocontrol.
  • Professor Gabriele Berg—Graz University of Technology, Austria; microbiology.
  • Professor Emeritus Richard A. Sikora —University of Bonn, Germany; nematology.
  • Dr. Trevor Jackson—AgResearch, New Zealand; entomology.
  • Emeritus Professor Roberta L. Farrell—University of Waikato, New Zealand; biochemistry.
  • Professor William Fenical—University of California, San Diego, USA; natural product chemistry.
  • Alan Knowles—Director & Principal Consultant, FORM-AK Ltd, UK; formulation science and technology.
  • Professor Orlando J. Rojas—North Carolina State University, USA; formulation engineering.
  • Emeritus Professor Baruch Rubin—Hebrew University of Jerusalem, Israel; weed science.
  • Professor Dr. Henk Noorman—DSM Biotechnology Center, The Netherlands; bioprocessing technology.

Additional information about the ISAP panel members can be found on the Marrone Bio Innovations website, www.marronebio.com.

About Marrone Bio Innovations
Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.


'/>"/>
SOURCE Marrone Bio Innovations
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Marrone Bio Innovations Breaks Ground on Michigan Manufacturing Facility
2. Marrone Bio Innovations’ CEO to Address European Biopesticide Industry at Informa Life Sciences Biopesticides Conference
3. Marrone Bio Innovations’ Zequanox® Demonstrates Control of Zebra Mussels in Illinois Lake
4. Marrone Bio Innovations Submits New Bioherbicide for EPA Registration
5. Marrone Bio Innovations Files Patent for a Unique Bacillus Species
6. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
7. Nanoantennas show promise in optical innovations
8. ARUP Laboratories Announces Creation of Business Innovations Division
9. 2012 Hannover Messe: Innovations by KIT
10. Air Innovations’ Environmental Control Projects Featured in Trade Media
11. Heartland Plant Innovations Wins Kansas Bioscience Authority Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2017)... ... May 20, 2017 , ... CNSDose ... lengthy trial and error process by finding the right antidepressant faster. CNSDose ... the doctor-patient relationship through a personalized approach to treatment. , A ...
(Date:5/18/2017)... ... May 18, 2017 , ... Dr. Ralph Mobbs of ... Prince Of Wales Private Hospital. The procedure was performed on a 46-year-old male ... conservative treatments prior to undergoing surgery. , The AxioMed viscoelastic disc is a ...
(Date:5/18/2017)... , ... May 17, 2017 , ... NDA Partners Chairman ... and former CEO of Eurofins Advantar Laboratories and President of Pharmaceutical Development Business Unit ... his position at Eurofins and Cardinal Health, he was former Chief Operating Officer at ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... optimization firm for the life sciences and healthcare industries, is honored that ... for Medical Devices conference in Brussels, Belgium. , Crowley played a crucial role ...
Breaking Biology Technology:
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
Breaking Biology News(10 mins):